When the UK team studied antiepileptic drugs (AEDs) given to nearly 8,000 children over a 13-year period, they discovered that overall prescribing had risen by 19 per cent and there had been a five-fold increase in prescribing of newer AEDs.
The results follow a report by the European Medicines Agency (EMEA) which called for greater research into paediatric drugs for epilepsy.
“EMEA recommended further research into 21 antiepileptic drugs for children but didn’t indicate which ones should be prioritised” explains Professor Ian Wong from the Centre for Paediatric Pharmacy Research, a collaborative project run by the School of Pharmacy at the University of London, the UCL Institute of Child Health and Great Ormond Street Hospital.
“Our research has narrowed that list down to three drugs that have seen a massive rise in UK prescribing since 1993 – lamotrigine, topiramate and levetiracetam. The uptake of these drugs has been rapid, yet their long-term safety has not been established and further research must now be seen as a priority.”
Worldwide concern has been expressed about the need to reform regulations and develop better research structures for paediatric medicines, says Professor Wong, who is also a member of TEDDY - the Task-force of European Drug Development for the Young.
“The American Food and Drug Administration and the National Institutes of Health have been leading the process for paediatric drug reform over the last ten years. And the European Union has proposed the “Better Medicines for Children” regulation and devised a research strategy to improve paediatric medicines research in the hope of increasing the availability of licensed medicines for children” he says.
Concerns over paediatric AEDs have risen in recent years after prescribing restrictions were issued on vigabatrin in the late 1990s following reports that one-third of users suffered from visual field defects, ranging from asymptomatic to severe and potentially disabling.
In 2004, the National Institute for Health and Clinical Excellence – the UK Government’s advisory body on therapeutic interventions – stated that vigabatrin should only be prescribed in cases of West’s Syndrome (infantile spasms) and then only by an epilepsy specialist, a neurologist or a paediatric neurologist.
Professor Wong and his research colleagues studied 7,721 patients from birth to 18, using data from the UK General Practice Research Database, analysing the results by age and the AED prescribed.
Their findings included:
- More than a quarter of a million prescriptions (257,663) were issued for AEDs during the study period. Of these, 69 per cent were for conventional AEDs and 31 per cent were for newer AEDs.
- The most commonly prescribed newer AED was lamotrigine, which accounted for 20 per cent of all prescriptions and 65 per cent of newer AED prescriptions.
- Valproate was the most commonly prescribed conventional AED, accounting for 36 per cent of all prescriptions and 52 per cent of conventional AED prescriptions.
- 54 per cent of children receiving prescriptions were male and prescribing for new patients was highest in the two to 11 age group (45 per cent) and the 12 to 18 age group (39 per cent). 16 per cent of prescriptions were for children under two years of age.
- 70 per cent of children were receiving just one AED, which is consistent with adult research, which suggests that 60 to 70 per cent of patients have their epilepsy controlled by one AED.
“To our knowledge this is the first large paediatric study to compare newer and conventional AED prescribing in the UK” says Professor Wong, who – as a result of the study - has been awarded a research contract by the Medicine and Healthcare products Regulatory Agency to assess deaths among children and adolescents using antiepileptic drugs.
“Our research found that paediatric prescribing of antiepileptic drugs showed a significant increase over the study period and that newer AEDs are increasingly being prescribed in preference to more tried and tested conventional drugs.
“Newer AEDs have proved popular, mainly because they are less likely to react with other prescribed drugs.
“However, these newer AEDs are subject to fewer licensing restrictions because there is more evidence about their benefits, gathered from controlled trials, than their more traditional counterparts. As new safety data emerges, restrictions in prescribing may be implemented.”
“Many drugs are not tested on children before they are licensed because of the difficulties of including children in clinical trials” adds Dr Jeffrey Aronson, Editor-in-Chief of the Journal and Reader in Clinical Pharmacology at Oxford University.
“This means that clinicians often have to rely on their experience and scale down adult drugs for paediatric use, which is widely regarded as most unsatisfactory.
“The research by Wong and colleagues highlights this important problem, by providing us with an excellent picture of prescribing trends for children with epilepsy. We hope that this important piece of research will help to inform research priorities for the newer AEDs.
“It also raises concerns about the rapid increase in prescribing drugs whose safety has not been established for paediatric use, which is an issue that the Journal has often dealt with and will continue to cover.”
The authors have stressed that it is important that parents continue to give their children medicines that have been prescribed for them, but to make their family doctor or consultant aware of any adverse effects or problems their child experiences.
Annette Whibley | alfa
WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf
First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.
Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...
A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.
Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
18.05.2018 | Power and Electrical Engineering
18.05.2018 | Information Technology
18.05.2018 | Information Technology